Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Entera Bio (ENTX) Income towards Parent Company (2018 - 2025)

Entera Bio has reported Income towards Parent Company over the past 8 years, most recently at -$3.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 28.46% year-over-year to -$3.0 million, compared with a TTM value of -$11.5 million through Dec 2025, down 19.88%, and an annual FY2025 reading of -$11.4 million, down 19.89% over the prior year.
  • Income towards Parent Company came in at -$3.0 million for Q4 2025, up from -$3.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$2.0 million in Q4 2023 to a low of -$4.1 million in Q4 2021.
  • Median Income towards Parent Company over the past 5 years was -$2.6 million (2021), compared with a mean of -$2.8 million.
  • The largest YoY upside for Income towards Parent Company was 78.34% in 2021 against a maximum downside of 297.91% in 2021.
  • Over 5 years, Income towards Parent Company stood at -$4.1 million in 2021, then grew by 25.98% to -$3.0 million in 2022, then surged by 34.27% to -$2.0 million in 2023, then dropped by 18.2% to -$2.4 million in 2024, then dropped by 28.46% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Income towards Parent Company are -$3.0 million (Q4 2025), -$3.3 million (Q3 2025), and -$2.7 million (Q2 2025).